Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT05733364 Active, not recruiting - Healthy Clinical Trials

Effect of 4 Weeks Supplementation of a Combination of Vitamin Bs and Taurine on Mental Performance in Healthy Adults

Start date: March 8, 2023
Phase: N/A
Study type: Interventional

To evaluate the efficacy of the intervention in improving Motivation. To evaluate the efficacy of the intervention in improving Fatigue, Motivation/Vigor, Focus/Sustained Attention and blood levels of B vitamins and taurine.

NCT ID: NCT05694182 Active, not recruiting - Healthy Clinical Trials

The Safety and Efficacy of an Oral Superfruits Supplement

Start date: December 1, 2022
Phase: N/A
Study type: Interventional

This study is conducted to evaluate the safety and effectiveness of an oral superfruits supplement for skin brightening and wrinkle reduction. Superfruits are reported to have high bioactive compounds with beneficial effects on human health. The study duration is 12 weeks and the skin assessment will be carried out at baseline, week 2, week 6 and week 12. The participants will consume the supplement for 6 weeks and at week 12, final skin assessment will be conducted. The main questions this study aims to answer are: 1. The skin brightening effect of the oral superfruits supplement. 2. The effect of the oral superfruits supplement on wrinkle reduction. 3. To observe any adverse effect occurrence with the consumption of the oral superfruits supplement.

NCT ID: NCT05678426 Active, not recruiting - Healthy Clinical Trials

TirolGESUND: Baseline-controlled Comparison of the Effects of Fasting Dietary Intervention or Smoking Cessation Combined With Exercise in Healthy Female Tyrolean Volunteers Aged 30-60 on Epigenetic and Multi-omic Biomarkers of Health, Ageing, and Disease

TirolGESUND
Start date: April 21, 2021
Phase: N/A
Study type: Interventional

The goal of this clinical study is to learn about disease-risk and age-associated changes in DNA methylation patterns associated with disease risk or age in healthy women aged 30-60 in response to health-promoting lifestyle intervention (intermittent fasting or smoking cessation). The main questions the study aims to answer are: - Are the scores of DNA methylation in epigenetic signatures associated with age, women's cancer risk, or risk exposure reduced after 6 months of lifestyle intervention compared to baseline? - What are the dynamics of DNA methylation changes during or following intervention, and do differences in changes between different sample types exist? - Which other biomarkers of health and disease, including metabolic changes, microbiome, clinical, mental, or inflammatory parameters, are altered following intervention? The investigators also aim to explore whether DNA methylation changes are associated with changes in other biomarkers mentioned above. Participants will be allocated to intermittent fasting or smoking cessation based on inclusion criteria. Intermittent fasting encompasses a 16:8 intermittent fasting schedule. Food intake is limited to an 8 h window per day with fasting for the remaining 16 h. Within the intermittent fasting study, participants are randomised to receive a ketogenic supplement (medium-chain triglyceride fibre) or not. Participants in the smoking cessation study will be guided to stop smoking. All participants will receive 1:1 personal coaching throughout the study, and will be provided with an optional exercise programme. All participants will also receive nutritional advice from a professional dietician throughout the study. Participants are invited to donate samples every 2 months for 6 months. Researchers will compare signatures at the start and after 6 months of intervention. Within the intermittent fasting group, researchers will compare effects in individuals that received the ketogenic supplement to those that did not.

NCT ID: NCT05600348 Active, not recruiting - Healthy Clinical Trials

Dose-dependent Identification of Unique Biomarkers

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

The purpose of the research is to assess the dose-dependent impacts of the consumption of fresh pork on blood-borne metabolites (markers) following the controlled feeding of pork

NCT ID: NCT05560048 Active, not recruiting - Healthy Clinical Trials

Anti-exercise-fatigue Effects of Rice Protein RP-80NY in Men

Start date: September 30, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the anti-exercise-fatigue effects of rice protein RP-80NY in men

NCT ID: NCT05541133 Active, not recruiting - Healthy Clinical Trials

Effect of Acute Exercise on Exosome Associated Biomarkers

Start date: June 21, 2022
Phase:
Study type: Observational

This research study is being done to understand the underlying mechanism by which exercise affects the body on the cellular level, in an acute aerobic endurance setting. This may help to better understand the overall benefits of endurance exercise.

NCT ID: NCT05517122 Active, not recruiting - Healthy Clinical Trials

Effect of Oral NAD+ Precursors Administration on Blood NAD+ Concentration in Healthy Adults

Start date: June 27, 2022
Phase: N/A
Study type: Interventional

Nicotinamide adenine dinucleotide (NAD) is a coenzyme playing a central role in human metabolic pathways. A recognized approach to increase NAD level is through oral supplementation of its precursors promoting NAD synthesis in vivo. NAD precursors exist in multiple forms. However, it is unclear how the various precursors compare in their ability to increase NAD levels in human blood. The purpose of this study is to compare the effect of 3 NAD precursors on whole blood NAD metabolome.

NCT ID: NCT05516940 Active, not recruiting - Healthy Clinical Trials

A Study of the Impact of Different Delivery Modes on Specific Macronutrient Components in Human Milk

ZoomMING
Start date: May 6, 2022
Phase:
Study type: Observational

The aim of the study is to evaluate the impact of different delivery modes on specific macronutrient components in human milk.

NCT ID: NCT05496738 Active, not recruiting - Healthy Clinical Trials

A Preliminary Study to Evaluate PF-07264660 in Healthy Participants

Start date: August 16, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this clinical trial is to learn about the safety and effects of study medicine PF-07264660 compared to a placebo. This is the first study of PF-07264660 in humans. All participants in this study will received PF-07264660 or a placebo and it will be assigned by chance. People may be able to participate if they are healthy. The study medicine may be given by shots under the skin or through a vein depending on which group you are assigned to. If you are assigned into Part A, you will receive the study medicine once, stay overnight at the research unit from 3 to 5 overnight stays and you will need to visit the clinic about 11 follow-up visits. Participants will be in this study for up to about 541 days. If you are assigned into Part B, you will receive the study medicine three times, stay overnight at the clinic from 3 to 5 overnight stays and you will need to visit the research unit about 12 follow-up visits. Participants willbe in this study for up to about 561 days.

NCT ID: NCT05426772 Active, not recruiting - Healthy Clinical Trials

Investigation of the Effect of Kinesiotape Applied With Exercise on Muscle Oxygenation With Moxy Muscle Oxygen Monitor

Start date: September 16, 2021
Phase: N/A
Study type: Interventional

Kinesio taping (KT) is an elastic adhesive tape with physiological effects, often used in rehabilitation and sports medicine. KT, which can stay in the body for 3 to 5 days, exerts a pulling force on the skin thanks to its wave-like structure and elasticity, and increases the gap between the subcutaneous soft tissue and fascia with its lifting effect. In this way, it reduces the superficial pressure and causes an increase in lymph circulation. In addition, with the effect it creates on the muscles, it allows maximum contraction and relaxation of the muscle and creates positive effects on the deep lymphatics. Another effective approach to increase blood circulation is exercise. Exercise, which is known to have many benefits, has been shown to increase both systemic circulation and muscle blood flow. There are findings in the literature that KT can increase the effectiveness of exercise, but it has been stated that this issue is not clear and more studies are needed. In order to evaluate the effects of KT on increasing the effectiveness of exercise and on circulation, the oxygen saturation of the muscle in the application area can be measured. As a matter of fact, "Moxy muscle oxygen monitor" has been used in the literature, which measures regional oxygen saturation (SmO2) and total hemoglobin (THb) in capillaries under the muscle. The Moxy muscle oxygen monitor is a lightweight (42 g) and small (dimensions: 61 × 44 × 21 mm) device that measures regional blood flow and oxygenation by placing it on the skin non-invasively with near-infrared spectroscopy (NIRS). Its validity in measuring muscle oxygenation was vigorous or fairly good, and its reliability was found to be moderate to high in low-intensity exercises (SROC: r = 0.842-0.993, ICC: r = 0.773-0.992, p < .01). It is thought that the application of KT, which is known to increase lymphatic and venous circulation, together with exercise will increase the amount of oxygen in the muscles. To the best of our knowledge in the literature, no study has been found in which this effect of KT is presented objectively. For this reason, it is aimed to examine muscle oxygenation with the Moxy muscle oxygen monitor, which provides objective data on KT applied with exercise.